Another pro-inflammatory cytokine IL-1β is also significantly released into the cerebrospinal fluid of MS patients in the active disease state [61], and higher levels are closely related to a more severe progression and poor prognosis of patients with a relapsing-remitting MS [62, 63]. Here, IL1B is linked to myeloid sarcoma.